The benefits and limitations associated with nanoparticle-based therapies, including safety concerns and regulatory challenges, are critically examined and future perspectives on the clinical translation and advancement of nanomedicine are highlighted.
Abstract
Nanotechnology has emerged as a transformative approach in modern medicine, offering innovative strategies for disease diagnosis, treatment, and prevention. Nanoparticles, typically ranging from 1 to 100 nm in size, possess unique physicochemical properties that enable targeted drug delivery, enhanced therapeutic efficacy, and reduced systemic toxicity. This review provides a comprehensive overview of the major types of nanoparticles used in disease treatment, including lipid-based, polymeric, metallic, magnetic, and carbon-based nanoparticles. Their applications across various disease domains, such as cancer, infectious diseases, neurological disorders, and cardiovascular conditions, are discussed. In addition, the benefits and limitations associated with nanoparticle-based therapies, including safety concerns and regulatory challenges, are critically examined. Finally, future perspectives on the clinical translation and advancement of nanomedicine are highlighted.
Nanoparticle-based drug delivery systems have become an important component of modern nanomedicine, enabling improved drug protection, controlled release, targeted delivery, and the modulation of pharmacokinetic behavior. Their therapeutic performance is governed by physicochemical properties such as size, shape, surfa...
Subin Antony Jose, Benjamin Crutchfield, M. Caballero et al.· Molecules· 1 citation
This review paper provides an integrated and critical perspective on next-generation nanomedicine by connecting nanocarrier design with tumor-specific accumulation, intracellular trafficking, stimuli-responsive drug release, combination therapy and clinical translation.
Biswajit Mohanty, P. Saikia, Piyush Pandey et al.· Frontiers in Chemistry· 0 citations
This review provides a comprehensive overview of state-of-the-art lipid-based delivery systems specifically designed to overcome the unique pharmaceutical challenges associated with therapeutic glycoproteins, highlighting their design principles, formulation strategies, mechanisms of encapsulation and release, and ther...
The evidence supports early integration of efficacy, mechanistic toxicology, CMC, and patient-specific risk rather than downstream safety testing alone, and indicates Harmonized characterization, clinically relevant models, long-term fate studies, and lifecycle surveillance remain central priorities for the next genera...
Taís Magne Ramos, L. Alencar, Eduardo Ricci-Júnior et al.· International Journal of Nan...· 1 citation
The current role of green-synthesized NPs in renal cell carcinoma management and their applications in targeted drug delivery and cancer-specific targeting mechanisms are focused on and the environmentally friendly green synthesis approaches utilizing biological resources such as plant extracts and microorganisms are h...
Mariam R. Khalifa, Doaa S. R. Khafaga, Marwa T. Abo Gabal et al.· International Journal of Mol...· 0 citations
Advances in nanotechnology have produced a range of strategies for cancer treatment. Among the materials under investigation, Gold Nanoparticles (AuNPs) are attractive candidates for immunotherapy because of their distinctive physicochemical properties and biocompatibility.
This narrative review draws on stu...
V. R. Jallepalli, Angum M. M. Ibrahim, Anasuya Patil et al.· Current Nanomedicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
